SCHEDULE OF PRINCIPAL ACTIVITIES OF SUBSIDIARIES (Details) |
12 Months Ended | 24 Months Ended | |
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2025 |
|
| Advance Cancer Centre Pte Ltd [member] | |||
| IfrsStatementLineItems [Line Items] | |||
| Name of entity | Advance Cancer Centre Pte Ltd | Advance Cancer Centre Pte Ltd | |
| Principal activities | Investment, research and development of medical technologies | Investment, research and development of medical technologies | |
| Country of business / incorporation | Singapore | Singapore | |
| Ownership percentage | 100.00% | 100.00% | |
| CytoMed Therapeutics (Malaysia) Sdn Bhd [member] | |||
| IfrsStatementLineItems [Line Items] | |||
| Name of entity | CytoMed Therapeutics (Malaysia) Sdn Bhd | CytoMed Therapeutics (Malaysia) Sdn Bhd | |
| Principal activities | Research, development and manufacturing of stem cells and innate immune cell-based immune-therapeutics, research and development of induced pluripotent stem cell-based immune-therapeutics | Research, development and manufacturing of stem cells and innate immune cell-based immune-therapeutics, research and development of induced pluripotent stem cell-based immune-therapeutics | |
| Country of business / incorporation | Malaysia | Malaysia | |
| Ownership percentage | 100.00% | 100.00% | |
| LongevityBank Pte Ltd [member] | |||
| IfrsStatementLineItems [Line Items] | |||
| Name of entity | LongevityBank Pte Ltd | LongevityBank Pte Ltd | |
| Principal activities | Stem cell and immune cell banking | Stem cell and immune cell banking | |
| Country of business / incorporation | Singapore | Singapore | |
| Ownership percentage | 77.00% | 90.00% | |
| IPSC Depository Sdn Bhd [member] | |||
| IfrsStatementLineItems [Line Items] | |||
| Name of entity | IPSC Depository Sdn Bhd | IPSC Depository Sdn Bhd | |
| Principal activities | Processing and banking of cells including cord blood stem cells and development on cell-based therapy | Processing and banking of cells including cord blood stem cells and development on cell-based therapy | |
| Country of business / incorporation | Malaysia | Malaysia | |
| Ownership percentage | 77.00% | 90.00% | |
| Puricell Lab Pte Ltd [member] | |||
| IfrsStatementLineItems [Line Items] | |||
| Name of entity | Puricell Lab Pte Ltd | Puricell Lab Pte Ltd | |
| Principal activities | Research and development of induced pluripotent stem cell-based biologics and medical technologies | Research and development of induced pluripotent stem cell-based biologics and medical technologies | |
| Country of business / incorporation | Singapore | Singapore | |
| Ownership percentage | 73.00% | 95.00% | |